Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial | Synapse
January 2, 2020Open Access
Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial
Key Points
Key points are not available for this paper at this time.
Abstract
This trial was supported by Novo Nordisk A/S, Denmark.